• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    OlivePoint Capital Acquires 3900 Paramount Parkway in Raleigh–Durham, Expanding Its High-Conviction Office Special Situations Strategy

    12/15/25 10:11:00 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials
    Get the next $TMO alert in real time by email

    OlivePoint Capital ("OlivePoint"), an institutional real estate investment manager focused on thematic and special situations strategies, and Redwood Capital Management, LLC, a global alternative investment manager focused on opportunistic credit and other special situation investments ("Redwood Capital"), today announced its acquisition of 3900 Paramount Parkway, a 220,000-square-foot Class A office building located within Research Triangle Park (RTP) in Raleigh–Durham, one of the fastest-growing innovation hubs in the United States.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215054691/en/

    3900 Paramount Parkway - Raleigh, NC

    3900 Paramount Parkway - Raleigh, NC

    The property is 100% leased to Pharmaceutical Product Development (PPD), a subsidiary of Thermo Fisher Scientific (NYSE:TMO) - a global leader in life sciences with an A– S&P credit rating - and benefits from a long lease duration and full corporate credit support.

    A Contrarian, Data-Driven Bet on Mispriced Quality

    By acquiring the asset at a meaningful discount to both replacement cost and at a very attractive in-place yield - OlivePoint continues to execute its conviction that today's dislocation in the office sector is creating rare entry points for investors.

    "As office headlines remain negative, we see what many market participants are missing: when an entire asset class falls out of favor, pricing often disconnects from fundamentals," said Adrian Bejarano, Co-Founder & Managing Partner at OlivePoint. "Our job is to parse signal from noise. In select pockets of the market - especially where credit, location, and replacement cost dynamics remain strong - today's environment offers compelling return opportunities. Paramount Parkway is a prime example of an institutional-quality asset overlooked in a broad market selloff."

    Ruben Kliksberg and Sean Sauler, Co-CIOs of Redwood Capital Management, stated: "We are excited to partner with OlivePoint on this investment at 3900 Paramount Parkway. The property's strong cash-flow profile with a high-quality tenant, and strategic position within a rapidly growing market, make it an attractive investment that fits within our mandate of identifying mispriced risk and special situations with attractive return profiles driven by scarcity of capital in stressed areas of the market."

    Why Raleigh–Durham

    Positioned adjacent to the RTP campus - home to more than 375 companies across biotech, pharma, tech, and advanced manufacturing - the property sits within one of the country's most dynamic and rapidly growing metros. Raleigh-Durham ranks among the top markets nationally for long-term population and income growth and continues to attract leading global employers.

    "RTP is one of the few ecosystems nationally where tenant demand is rooted in mission-critical research, engineering, and life sciences work," said John Bruno, Partner at OlivePoint. "We expect that growth and innovation will continue to reinforce the long-term value of well-located assets like Paramount Parkway."

    A Strategy Built for Dislocation

    The acquisition reinforces OlivePoint's broader Office Special Situations Strategy, which targets durable, credit-backed cash flows, strategic locations, and assets with clear downside protection - particularly where capital markets pressure has forced motivated selling.

    "Our team has spent decades investing through complex, shifting markets," added Bruno. "Periods of dislocation have consistently been some of the most attractive times to deploy capital. We're committed to leaning in where we see value and letting data - not sentiment - guide our decisions."

    About OlivePoint Capital

    OlivePoint Capital is a Los Angeles–based private real estate investment manager focused on lower-middle-market special situations and thematic opportunities across the United States. The firm combines institutional experience with hands-on execution to uncover opportunities often overlooked by traditional capital. OlivePoint manages capital on behalf of leading institutional investors, including pension funds, fund-of-funds, and family offices.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251215054691/en/

    Press Contact

    info@olivepointcapital.com

    www.olivepointcapital.com

    Get the next $TMO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TMO

    DatePrice TargetRatingAnalyst
    12/11/2025$660.00Neutral → Buy
    Citigroup
    12/9/2025$685.00Buy
    Goldman
    12/8/2025$750.00Sector Weight → Overweight
    KeyBanc Capital Markets
    12/2/2025$670.00Overweight
    Morgan Stanley
    12/1/2025$670.00Hold → Buy
    HSBC Securities
    9/11/2025$550.00Equal Weight → Overweight
    Barclays
    8/19/2025Outperform
    William Blair
    7/24/2025$510.00Buy → Hold
    HSBC Securities
    More analyst ratings

    $TMO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Thermo Fisher upgraded by Citigroup with a new price target

    Citigroup upgraded Thermo Fisher from Neutral to Buy and set a new price target of $660.00

    12/11/25 8:46:38 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Goldman initiated coverage on Thermo Fisher with a new price target

    Goldman initiated coverage of Thermo Fisher with a rating of Buy and set a new price target of $685.00

    12/9/25 8:54:23 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Thermo Fisher upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded Thermo Fisher from Sector Weight to Overweight and set a new price target of $750.00

    12/8/25 8:17:51 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    $TMO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    OlivePoint Capital Acquires 3900 Paramount Parkway in Raleigh–Durham, Expanding Its High-Conviction Office Special Situations Strategy

    OlivePoint Capital ("OlivePoint"), an institutional real estate investment manager focused on thematic and special situations strategies, and Redwood Capital Management, LLC, a global alternative investment manager focused on opportunistic credit and other special situation investments ("Redwood Capital"), today announced its acquisition of 3900 Paramount Parkway, a 220,000-square-foot Class A office building located within Research Triangle Park (RTP) in Raleigh–Durham, one of the fastest-growing innovation hubs in the United States. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215054691/en/3900 Paramount Parkway - Raleigh,

    12/15/25 10:11:00 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Thermo Fisher Scientific Deepens Investment in Asia's Biopharma Ecosystem with Expansion of Bioprocess Design Centers

    New and expanded facilities provide local expertise, advanced technologies and tailored support for biopharma innovators throughout the region Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitment to supporting the region's rapidly growing biopharmaceutical industry. The company is introducing a new Bioprocess Design Center in Hyderabad, India, and has expanded its existing Bioprocess Design Centers in Incheon, Korea and Singapore, further strengthening a strategic regional network designed to enhance speed, efficiency and sustainability in biomanufacturing. Asia is an emer

    12/2/25 5:00:00 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes

    Thermo Fisher Scientific Inc. (NYSE:TMO) ("Thermo Fisher") announced today that it has priced an offering of €2.1 billion aggregate principal amount (the "Offering") of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly-owned finance subsidiary: €1,000,000,000 aggregate principal amount of its floating rate senior notes due 2027 (the "floating rate notes") at the issue price of 100.000% of their principal amount; and €1,100,000,000 aggregate principal amount of its 3.628% senior notes due 2035 (the "fixed rate notes," and together with the floating rate notes, the "notes") at the issue price of 100.000% of their

    11/24/25 9:10:00 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    $TMO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Sperling Scott M gifted 4,386 shares, decreasing direct ownership by 6% to 68,980 units (SEC Form 4)

    4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)

    12/11/25 4:03:05 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Executive Vice President & COO Lagarde Michel exercised 40,683 shares at a strike of $120.07 and sold $12,424,244 worth of shares (22,046 units at $563.56), increasing direct ownership by 28% to 84,117 units (SEC Form 4)

    4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)

    12/5/25 4:40:22 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Executive Vice President & COO Lagarde Michel exercised 104,000 shares at a strike of $105.17 and sold $36,126,126 worth of shares (62,000 units at $582.68), increasing direct ownership by 179% to 65,480 units (SEC Form 4)

    4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)

    12/4/25 4:46:00 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    $TMO
    SEC Filings

    View All

    SEC Form CERT filed by Thermo Fisher Scientific Inc

    CERT - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)

    12/8/25 1:03:05 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    SEC Form 144 filed by Thermo Fisher Scientific Inc

    144 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Subject)

    12/2/25 10:00:46 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Thermo Fisher Scientific Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)

    12/1/25 4:15:51 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    $TMO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Chai Nelson sold $8,449 worth of shares (16 units at $528.09) and bought $11,038 worth of shares (20 units at $551.90), increasing direct ownership by 0.03% to 14,252 units (SEC Form 4)

    4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)

    2/21/25 4:19:32 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Boxer Michael A bought $2,105 worth of shares (4 units at $526.15), increasing direct ownership by 0.03% to 13,101 units (SEC Form 4)

    4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)

    10/6/23 4:23:51 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    $TMO
    Leadership Updates

    Live Leadership Updates

    View All

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    Thermo Fisher Scientific's Chief Financial Officer, Stephen Williamson, to Retire in Early 2026

    Jim Meyer to Become Chief Financial Officer, Effective March 1, 2026 Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that Stephen Williamson, senior vice president and chief financial officer (CFO), has decided to retire from the company, effective March 31, 2026. The company's board of directors has approved the appointment of Jim Meyer, currently vice president of financial operations, to succeed Williamson as CFO, effective March 1, 2026. Williamson, age 58, has led Thermo Fisher's global finance organization as CFO since 2015. He joined the company in 2001 as Vice President, European Financial Operations. To ensure a seamless transition

    7/23/25 9:00:00 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    908 Devices Appoints Christopher D. Brown to its Board of Directors

    908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, Analytics R&D at Repligen Corporation (NASDAQ:RGEN), and a 908 Devices Co-founder, to serve on its Board of Directors, effective immediately. Dr. Brown co-founded 908 Devices and served as the company's Chief Technology Officer & Vice President of Research & Development from February 2012 to March 2023, and as its Chief Product Officer from March 2023 until March 2025 when Repligen purchased the company's bioprocessing portfolio. Prior to 908 Devices, Dr. Brown was a platform architect at Apple Inc. (NASDAQ:AAPL) lead

    6/16/25 8:00:00 AM ET
    $AAPL
    $MASS
    $RGEN
    Computer Manufacturing
    Technology
    Industrial Machinery/Components
    Industrials

    $TMO
    Financials

    Live finance-specific insights

    View All

    OlivePoint Capital Acquires 3900 Paramount Parkway in Raleigh–Durham, Expanding Its High-Conviction Office Special Situations Strategy

    OlivePoint Capital ("OlivePoint"), an institutional real estate investment manager focused on thematic and special situations strategies, and Redwood Capital Management, LLC, a global alternative investment manager focused on opportunistic credit and other special situation investments ("Redwood Capital"), today announced its acquisition of 3900 Paramount Parkway, a 220,000-square-foot Class A office building located within Research Triangle Park (RTP) in Raleigh–Durham, one of the fastest-growing innovation hubs in the United States. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215054691/en/3900 Paramount Parkway - Raleigh,

    12/15/25 10:11:00 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Thermo Fisher Scientific Declares Quarterly Dividend

    Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.43 per common share, payable on January 15, 2026, to shareholders of record as of December 15, 2025. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the dev

    11/6/25 4:30:00 PM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    Thermo Fisher Scientific Reports Third Quarter 2025 Results

    Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 27, 2025. Third Quarter Highlights Third quarter revenue grew 5% to $11.12 billion. Third quarter GAAP diluted earnings per share (EPS) was $4.27, in-line with the prior-year quarter. Third quarter adjusted EPS grew 10% to $5.79. Delivered excellent operational performance in the quarter demonstrating the strength of our proven growth strategy, the power of our PPI Business System, and the continued active management of our company. Advanced our proven growth strategy, launching a range of high-impact, innovative new p

    10/22/25 6:00:00 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    $TMO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Thermo Fisher Scientific Inc (Amendment)

    SC 13G/A - THERMO FISHER SCIENTIFIC INC. (0000097745) (Subject)

    2/9/23 11:35:13 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed

    SC 13G/A - THERMO FISHER SCIENTIFIC INC. (0000097745) (Subject)

    2/10/21 11:57:23 AM ET
    $TMO
    Industrial Machinery/Components
    Industrials